Here are the latest quarterly results of INDOCO REMEDIES. For more details, see the INDOCO REMEDIES financial fact sheet and INDOCO REMEDIES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,091 | 4,082 | 4,330 | 3,992 | 4,282 | 4,265 | 4,817 | 4,594 | |
Other income | Rs m | 3 | 11 | 4 | 4 | 5 | 4 | 44 | 24 | |
Turnover | Rs m | 4,094 | 4,094 | 4,334 | 3,996 | 4,287 | 4,269 | 4,862 | 4,618 | |
Expenses | Rs m | 3,286 | 3,368 | 3,452 | 3,372 | 3,634 | 3,653 | 4,104 | 3,965 | |
Gross profit | Rs m | 805 | 715 | 879 | 620 | 648 | 612 | 714 | 547 | |
Depreciation | Rs m | 181 | 201 | 157 | 172 | 177 | 199 | 214 | 244 | |
Interest | Rs m | 30 | 41 | 53 | 70 | 86 | 78 | 81 | 101 | |
Profit before tax | Rs m | 598 | 484 | 673 | 382 | 389 | 339 | 463 | 226 | |
Tax | Rs m | 193 | 98 | 176 | 101 | 131 | 97 | 110 | 71 | |
Profit after tax | Rs m | 405 | 386 | 497 | 282 | 258 | 242 | 352 | 156 | |
Gross profit margin | % | 19.7 | 17.5 | 20.3 | 15.5 | 15.1 | 14.3 | 14.8 | 11.9 | |
Effective tax rate | % | 32.3 | 20.2 | 26.1 | 26.3 | 33.7 | 28.7 | 23.9 | 31.2 | |
Net profit margin | % | 9.9 | 9.4 | 11.5 | 7.1 | 6.0 | 5.7 | 7.3 | 3.4 | |
Diluted EPS | Rs | 4.4 | 4.2 | 5.4 | 3.1 | 2.8 | 2.6 | 3.8 | 1.7 | |
Diluted EPS (TTM) | Rs | 16.8 | 16.7 | 17.6 | 17.0 | 15.4 | 13.9 | 12.3 | 10.9 | |
Subscriber Feature |
Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.